Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru

  • Jorge Alberto Gomez GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina
  • Maria Mercedes Castrejon GSK Vaccines Latin America, Panamá, Panamá
  • Nicolas Van de Velde GSK Vaccines, Wavre, Belgium
Keywords: Cost effectiveness, pneumococcal vaccines, Peru

Abstract

This item has no abstract. Follow the links below to access the full text.

Author Biography

Jorge Alberto Gomez, GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina
Senior Healrh Economic ManagerGSK Vaccines, Latin America
Published
2015-07-30
How to Cite
1.
Gomez JA, Castrejon MM, Van de Velde N (2015) Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru. J Infect Dev Ctries 9:796-798. doi: 10.3855/jidc.6827
Section
Letters to the Editor